Naturally Splendid Enterprises Ltd. (TSXV:NSP) announces the engagement of Dr. Amin Janmohamed as its Qualified Person In Charge (“QPIC”) in the Company’s application to become a Licensed Dealer. Additionally, Dr. Janmohamed has been appointed to Naturally Splendid’s Advisory Board where his extensive medical research and formulation experience will be a significant asset to the Company as strategic plans continue to evolve and focus on the nutraceutical and therapeutic applications for cannabinoids such as CBD (cannabidiol) and THC (Tetrahydrocannabinol).

Dr. Janmohamed is a researcher, clinical program developer and drug formulator in the area of severe opioid use disorder.  He is currently a researcher at CHEOS (Centre for Health Evaluation and Outcome Sciences) affiliated with Providence Health Care Research Institute and UBC Faculty of Medicine, and the CEO of Bixa Therapeutics Inc., Bixa Research Inc., and Bixa S.A. (Colombia). Dr. Janmohamed is a co-investigator in the SALOME clinical trial (Study to Access Long-term Opioid Medication).  Dr. Janmohamed’s extensive expertise covers in study-drug formulations, regulations, drug development, manufacturing, security, and program development of controlled substances in clinical trials and clinical treatment. Dr. Janmohamed has been published in several medical publications.  He holds a BSc (Pharm) from the University of British Columbia, and an MSc and PhD in Health Sciences from the Universidad Empresarial, Costa Rica.


Naturally Splendid CEO Mr. Douglas Mason states, “Engaging Dr. Janmohamed as our QPIC is a critical step towards Naturally Splendid becoming a Licensed Dealer in Canada. With his first-hand experience at obtaining and working under a Dealer’s License and his many years of research experience, he will be able to guide us through the process and provide invaluable insight. He has a wealth of history in the medical research and formulation field that will be invaluable on our Advisory Board as we pursue a number of activities related to cannabis and the extraction, formulation and distribution of cannabinoids.”

Becoming a Licensed Dealer creates the opportunity for several revenue streams including CBD and THC as well as other cannabinoids derived from hemp or marijuana, as it relates to extraction, distillation, product development, manufacturing and marketing of cannabinoid fortified products. According to the Prime Minister’s office, regulatory laws in Canada pertaining to the extraction of CBD from industrial hemp are anticipated to be amended in the summer of 2018. Becoming a Licensed Dealer positions Naturally Splendid to be a supplier of cannabis extracts and cannabis extract fortified products as well as the ability to perform a number of additional services as identified below each in accordance with the Canadian regulatory regime.

The regulatory purpose for a Licensed Dealer is to enable legal possession of controlled substances such as CBD and THC for the following purposes:

1) Manufacturing
2) Packaging
3) Preparation of R&D Formulations for future manufacturing
4) Resale and distribution to other licensees, including pharmacies
5) Importing and exporting for global sales
6) Laboratory testing
7) Contract activities for any of the above activities

In consideration for Dr. Janmohamed’s engagement as Qualified Person in Charge, NSE will issue a total of 200,000 common shares of the Company (the “NSP Shares”) as follows:

(a) 50,000 NSP Shares on the date of TSX Venture Exchange acceptance of this Agreement (the “Exchange Approval Date”);

(b) 10,000 NSP Shares on the date that is two months after the Effective Date;

(c) 10,000 NSP Shares on the date that is three months after the Effective Date;

(d) 10,000 NSP Shares on the date that is four months after the Effective Date;

(e) 10,000 NSP Shares on the date that is five months after the Effective Date;

(f) 10,000 NSP Shares on the date that is six months after the Effective Date;

(g) 100,000 NSP Shares on the first anniversary of this Agreement.

In consideration of Dr. Janmohamed’s appointment to Naturally Splendid’s Advisory Board, he will be granted 100,000 stock options at an exercise price of $0.20.

The issuance of the shares to Dr. Janmohamed is subject to the acceptance of the TSX Venture Exchange.

About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp and non-psychoactive cannabinoid compounds in a broad spectrum of applications.

Naturally Splendid currently has four innovative divisions:

(1) BIOTECHNOLOGY – Focused on three major platforms:

  1. Proprietary HempOmega™ encapsulation
  2. Extraction and formulation with Cannabidiol (CBD)
  3. Hemp and plant-based proteins.

(2) CONSUMER PRODUCTS –

  • NATERA® – brand of retail hemp and superfood products distributed throughout North America, Asia and Europe.
  • Prosnack Natural Foods Inc. (Elevate Me™) – lifestyle brand of healthy meal replacement products distributed throughout North America.
  • Chi Hemp Industries Incorporated (CHII) – e-commerce platform for natural and organic hemp products.
  • PawsitiveFX® – topical pet care products.
  • NATERA®CBD – retail hemp-based cannabinoid nutraceutical and cosmeceutical products distributed in Asia.
  • NATERA®Skincare – brand of retail hemp based cosmeceutical products.

(3) NATERA® Ingredients – bulk ingredients including HempOmega™.

(4) Co-Packaging/Toll-Processing – packaging for house-brands (NATERA® and CHII) and third-party partners.

For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-673-9573

On Behalf of the Board of Directors

Mr. Douglas Mason
CEO, Director

Contact Information

Naturally Splendid Enterprises Ltd.
(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office:  (604) 465-0548
Fax:      (604) 465-1128
E-mail: info@naturallysplendid.com
Website: www.naturallysplendid.com

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Click here to connect with Naturally Splendid Enterprises Ltd. (TSXV:NSP) and receive an Investors Presentation.

Source: globenewswire.com

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less